#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuronal ceroid lipofuscinosis Craniopharyngioma Acute promyelocytic leukaemia Hypergammaglobulinaemia benign monoclonal Mantle cell lymphoma Epileptic encephalopathy Nephroblastoma Liposarcoma recurrent Ductal adenocarcinoma of pancreas Neurofibromatosis B-cell small lymphocytic lymphoma recurrent Focal segmental glomerulosclerosis Hyperoxaluria Urea cycle disorder Mantle cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Diagnostics Progressive supranuclear palsy Biotinidase deficiency – Diagnostics Idiopathic pulmonary fibrosis – Trials in Disease Nodal marginal zone B-cell lymphoma – Life with Disease Lymphangioma – Life with Disease Hepatoblastoma Nephrotic syndrome – Trials in Disease Glycogen storage disease type I – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zasocitinib Rapcabtagene Autoleucel Gskvx000000008885 Satoreotide Tetraxetan TUVATEXIB Arginine Anidulafungin RO7795081 Specific Nucleic Acid Sna-Veru Clozapine Sevoflurane Treprostinil Magnesium Sulfate Acetylsalicylic Acid Omalizumab Aluminium Oxide SGN-ALPV 177Lu-Dpi-4452 Cangrelor Tetrasodium ICEF15 More therapies…

    Learn about Your Condition

    Stress Craniocerebral injury Multifocal motor neuropathy Alopecia areata Ewing's sarcoma metastatic Haemophilia Glaucoma Pemphigoid Leukocyte adhesion deficiency Noninfective chorioretinitis Gastrooesophageal cancer Stomatitis Orthostatic hypotension Hip arthroplasty Supraventricular tachycardia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pneumonia

  • Study of antibiotic combination therapy duration based on patient response for adults with community-acquired pneumonia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • Azithromycin
    • Demeclocycline Hydrochloride
    France

  • Study on the Safety and Tolerability of TP-122 for Treating Ventilator-Associated Pneumonia in Adults

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Demerecviridae Bacteriophage Against Klebesiella Pneumoniae (113.073 Bp)
    • Drexlerviridae Bacteriophage Against Klebesiella Pneumoniae (45.423 Bp)
    • Myoviridae Bacteriophage Against Klebesiella Pneumoniae (169.802 Bp)
    France

  • Study on Inhaled Levofloxacin for Treating Community-Acquired Pneumonia in Patients Without Systemic Antibiotics

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Levofloxacin
    • Saline
    • Piperacillin
    Denmark

  • Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Cholesterol
    • Sphingomyelin (Egg)
    • Sodium Chloride
    Belgium Czechia France Greece Hungary Latvia +3

  • Study of Baricitinib for Treating Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Baricitinib
    Belgium France The Netherlands Spain

  • Bioequivalence Study of Amoxicillin/Clavulanic Acid Oral Suspension Compared with Reference Product in Healthy Adult Volunteers under Fed Conditions

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Heparin Sodium
    • Amoxicillin
    • Clavulanic Acid
    Czechia
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!